The University of Texas System recognized three outstanding UTHealth Houston faculty for their teaching excellence and contributions to advancing health science education with induction into the 2027 class of The University of Texas Kenneth I. Shine, MD, Academy of Health Science Education.
For his innovative and tireless work in researching solutions for homelessness, Jack Tsai, PhD, professor at UTHealth Houston School of Public Health, is receiving the 2026 American Public Health Association’s (APHA) Award for Excellence.
Nearly 60 years after its founding, UTHealth Houston School of Public Health opened a new chapter with the debut of its 10-story facility in Helix Park during a ribbon-cutting ceremony Oct. 28.
UTHealth Houston celebrates grand opening of new Starr County border health research facility
February 27, 2026
UTHealth Houston School of Public Health researchers developed a new genetic framework model to improve the prediction of respiratory diseases among multi-ancestry populations, according to a new study.
February 27, 2026
UTHealth Houston School of Public Health researchers have developed a new genetic framework to improve the prediction of respiratory diseases among multi-ancestry populations, according to a new study.
February 23, 2026
The Heart Disease and Stroke Prevention Program at the UTHealth Houston Center for Health Promotion and Prevention Research is providing training to clinic staff at primary care clinics in Texas to equip them with practical, clinic-ready communication tools that have been proven to improve health outcomes related to hypertension.
February 20, 2026
UTHealth Houston again ranks among the nation’s leading institutions for National Institutes of Health research funding, according to the latest annual analysis by the Blue Ridge Institute for Medical Research.
February 6, 2026
A UTHealth Houston researcher reviewed existing scientific evidence on how exposure to “forever chemicals,” including per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs), may influence the risk of congenital heart defects in fetal cardiac development.
February 6, 2026
A UTHealth Houston researcher reviewed existing scientific evidence on how exposure to “forever chemicals,” including per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs), may influence the risk of congenital heart defects in fetal cardiac development.
January 26, 2026
After running a small pilot program for the past two years providing healthcare in laundromats, Jack Tsai, PhD, professor and regional dean in San Antonio, has secured a new $1.1 million grant to continue and expand the program for the next three years.
January 14, 2026
UTHealth Houston has been awarded more than $2.9 million from the Centers for Disease Control and Prevention (CDC) to continue and expand a five-year initiative focused on increasing colorectal cancer screening, follow-up, and treatment across Federally Qualified Health Centers (FQHCs) in Texas.
January 14, 2026
UTHealth Houston has been awarded more than $2.9 million from the Centers for Disease Control and Prevention (CDC) to continue and expand a five-year initiative focused on increasing colorectal cancer screening, follow-up, and treatment across Federally Qualified Health Centers (FQHCs) in Texas.
January 9, 2026
Since May 2025, second-year student at McGovern Medical School at UTHealth Houston, Yesmeena Shmaitelly, has played a pivotal role in advancing the Harris Health Food is Medicine (FIM) study, a multi-phased project providing fresh produce and nutrition education to at-risk pregnant mothers in the Greater Houston region.
